Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,9 USD | -18,80% | -11,38% | -82,91% |
Omzet 2022 | - | Omzet 2023 | 2,2 2,02 | Marktkapitalisatie | 13,61 mln. 12,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -73 mln. -67,09 mln. | Nettowinst (verlies) 2023 | -37 mln. -34 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 4,59 mln. 4,22 mln. | Nettoschuld 2023 | 11,23 mln. 10,32 mln. | EV/omzet 2023 | 11.278.476 x |
K/w-verhouding 2022 |
-0,98
x | K/w-verhouding 2023 |
-0,18
x | Werknemers | 16 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 98,42% |
Recentste transcriptie over Seelos Therapeutics, Inc.
1 dag | -18,80% | ||
1 week | -11,38% | ||
Lopende maand | -14,87% | ||
1 maand | -28,99% | ||
3 maanden | -71,35% | ||
6 maanden | -93,74% | ||
Lopend jaar | -82,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 64 | 01-01-87 |
Director of Finance/CFO | 52 | 01-01-19 | |
Karen Fusaro
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 77 | 01-09-21 | |
Richard Pascoe
CHM | Chairman | 60 | 01-03-13 |
Daniel O'Connor
BRD | Director/Board Member | 59 | 01-01-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-05-24 | 1,9 | -18,80% | 234 265 |
16-05-24 | 2,34 | +0,79% | 202 459 |
15-05-24 | 2,322 | +19,72% | 244 909 |
14-05-24 | 1,939 | -11,89% | 161 650 |
13-05-24 | 2,201 | +2,65% | 57 340 |
uitgestelde koers Nasdaq, 17 mei 2024 om 22:30 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-82,91% | 3,25 mln. | |
+9,42% | 115 mld. | |
+11,84% | 106 mld. | |
-1,05% | 21,96 mld. | |
-14,15% | 21,87 mld. | |
-5,29% | 19,21 mld. | |
-4,16% | 18,08 mld. | |
-38,29% | 17,71 mld. | |
+7,99% | 14,32 mld. | |
+36,24% | 12,42 mld. |